<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37773227</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1432-8798</ISSN><JournalIssue CitedMedium="Internet"><Volume>168</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>29</Day></PubDate></JournalIssue><Title>Archives of virology</Title><ISOAbbreviation>Arch Virol</ISOAbbreviation></Journal><ArticleTitle>Research progress on pathogenic and therapeutic mechanisms of Enterovirus A71.</ArticleTitle><Pagination><StartPage>260</StartPage><MedlinePgn>260</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00705-023-05882-8</ELocationID><Abstract><AbstractText>In recent years, enterovirus A71 (EV-A71) infection has become a major global public health problem, especially for infants and young children. The results of epidemiological research show that EV-A71 infection can cause acute hand, foot, and mouth disease (HFMD) and complications of the nervous system in severe cases, including aseptic pediatric meningoencephalitis, acute flaccid paralysis, and even death. Many studies have demonstrated that EV-A71 infection may trigger a variety of intercellular and intracellular signaling pathways, which are interconnected to form a network that leads to the innate immune response, immune escape, inflammation, and apoptosis in the host. This article aims to provide an overview of the possible mechanisms underlying infection, signaling pathway activation, the immune response, immune evasion, apoptosis, and the inflammatory response caused by EV-A71 infection and an overview of potential therapeutic strategies against EV-A71 infection to better understand the pathogenesis of EV-A71 and to aid in the development of antiviral drugs and vaccines.</AbstractText><CopyrightInformation>© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Jianmei</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0008-9270-3403</Identifier><AffiliationInfo><Affiliation>Academy of Pediatrics, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhishan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Academy of Pediatrics, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Lixin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The First People's Hospital of Foshan, Foshan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yunxia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Sixth Clinical College, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Zifei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Academy of Pediatrics, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Chunhong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Academy of Pediatrics, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Jiachun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Academy of Pediatrics, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Lingqing</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-4630-7721</Identifier><AffiliationInfo><Affiliation>Qingyuan People's Hospital, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan, China. lingqing_xu@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Austria</Country><MedlineTA>Arch Virol</MedlineTA><NlmUniqueID>7506870</NlmUniqueID><ISSNLinking>0304-8608</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37773227</ArticleId><ArticleId IdType="doi">10.1007/s00705-023-05882-8</ArticleId><ArticleId IdType="pii">10.1007/s00705-023-05882-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cox B, Levent F (2018) Hand, Foot, and Mouth Disease. JAMA 320:2492. https://doi.org/10.1001/jama.2018.17288</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2018.17288</ArticleId><ArticleId IdType="pubmed">30561482</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez G, Carr MJ, Kobayashi M et al (2019) Enterovirus-Associated Hand-Foot and Mouth Disease and Neurological Complications in Japan and the Rest of the World. IJMS 20:5201. https://doi.org/10.3390/ijms20205201</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20205201</ArticleId><ArticleId IdType="pubmed">31635198</ArticleId><ArticleId IdType="pmc">6834195</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruu A-L (2002) Enteroviruses: Polioviruses, Coxsackieviruses, Echoviruses and Newer Enteroviruses. In: Haaheim LR, Pattison JR, Whitley RJ (eds) A Practical Guide to Clinical Virology. John Wiley &amp; Sons, Ltd, Chichester, UK, pp 44–45</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0470857285.ch6</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavan NA, Lavania M, Shinde P et al (2023) The 2022 outbreak and the pathobiology of the coxsackie virus [hand foot and mouth disease] in India. Infect Genet Evol 111:105432. https://doi.org/10.1016/j.meegid.2023.105432</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2023.105432</ArticleId><ArticleId IdType="pubmed">37030587</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Abzug MJ, Dominguez SR (2016) The Emergence of Enterovirus-D68. https://doi.org/10.1128/microbiolspec.EI10-0018-2016 . Microbiol Spectr 4:</Citation></Reference><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH (1974) An Apparently New Enterovirus Isolated from Patients with Disease of the Central Nervous System. J Infect Dis 129:304–309. https://doi.org/10.1093/infdis/129.3.304</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K-T, Chang H-L, Wang S-T et al (2007) Epidemiologic Features of Hand-Foot-Mouth Disease and Herpangina Caused by Enterovirus 71 in Taiwan, 1998–2005. Pediatrics 120:e244–e252. https://doi.org/10.1542/peds.2006-3331</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2006-3331</ArticleId><ArticleId IdType="pubmed">17671037</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardosa MJ, Krishnan S, Tio PH et al (1999) Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot, and mouth disease in Sibu, Sarawak. The Lancet 354:987–991. https://doi.org/10.1016/S0140-6736(98)11032-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(98)11032-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KP, Goh KT, Chong CY et al (2003) Epidemic Hand, Foot and Mouth Disease Caused by Human Enterovirus 71, Singapore. Emerg Infect Dis 9</Citation></Reference><Reference><Citation>Chan LG, Parashar UD, Lye MS et al (2000) Deaths of Children during an Outbreak of Hand, Foot, and Mouth Disease in Sarawak, Malaysia: Clinical and Pathological Characteristics of the Disease. Clin Infect Dis 31:678–683. https://doi.org/10.1086/314032</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/314032</ArticleId><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M, Chen E-R, Hsu K-H et al (1999) An Epidemic of Enterovirus 71 Infection in Taiwan. N Engl J Med 341:929–935. https://doi.org/10.1056/NEJM199909233411301</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P, Stratov I, Nagarajan L, Davis S (2001) Neurological Manifestations of Enterovirus 71 Infection in Children during an Outbreak of Hand, Foot, and Mouth Disease in Western Australia. Clin Infect Dis 32:236–242. https://doi.org/10.1086/318454</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/318454</ArticleId><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Tu P, Thao NTT, Perera D et al (2007) Epidemiologic and Virologic Investigation of Hand, Foot, and Mouth Disease, Southern Vietnam, 2005. Emerg Infect Dis 13:1733–1741. https://doi.org/10.3201/eid1311.070632</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1311.070632</ArticleId><ArticleId IdType="pubmed">18217559</ArticleId><ArticleId IdType="pmc">3375788</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Tan X-J, Wang H-Y et al (2009) An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol 44:262–267. https://doi.org/10.1016/j.jcv.2009.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2009.02.002</ArticleId><ArticleId IdType="pubmed">19269888</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu H, Shimizu Y, Takeuchi Y et al (1999) Outbreak of severe neurologic involvement associated with enterovirus 71 infection. Pediatr Neurol 20:17–23. https://doi.org/10.1016/S0887-8994(98)00087-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0887-8994(98)00087-3</ArticleId><ArticleId IdType="pubmed">10029254</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhu Z, Yang W et al (2010) An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of Hand Foot and Mouth Disease in Fuyang city of China. Virol J 7:1–9. https://doi.org/10.1186/1743-422X-7-94</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-94</ArticleId></ArticleIdList></Reference><Reference><Citation>M H (2000) Enterovirus 71: the virus, its infections and outbreaks. J Microbiol Immunol Infect 33:205–216</Citation></Reference><Reference><Citation>Gobara F, Itagaki A, Ito Y et al (1977) Properties of Virus Isolated from an Epidemic of Hand-Foot-and-Mouth Disease in 1973 in the City of Matsue: Comparison with Coxsackievirus Group A Type 16 Prototype. Microbiol Immunol 21:207–217. https://doi.org/10.1111/j.1348-0421.1977.tb00282.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1348-0421.1977.tb00282.x</ArticleId><ArticleId IdType="pubmed">875762</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagiwara A, Tagaya I, Yoneyama T (1978) Epidemic of Hand, Foot and Mouth Disease Associated with Enterovirus 71 Infection. Intervirology 9:60–63. https://doi.org/10.1159/000148922</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000148922</ArticleId><ArticleId IdType="pubmed">202573</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert GL, Dickson KE, Waters M-J et al (1988) Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement: The Pediatric. Infect Disease J 7:484–487. https://doi.org/10.1097/00006454-198807000-00007</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-198807000-00007</ArticleId></ArticleIdList></Reference><Reference><Citation>An L, Ga K, Va L, Mi M (2009) [Enterovirus 71: epidemiology and diagnostics]. Zhurnal mikrobiologii, epidemiologii i immunobiologii</Citation></Reference><Reference><Citation>Zhang Y, Tan X, Cui A et al (2013) Complete Genome Analysis of the C4 Subgenotype Strains of Enterovirus 71: Predominant Recombination C4 Viruses Persistently Circulating in China for 14 Years. PLoS ONE 8:e56341. https://doi.org/10.1371/journal.pone.0056341</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0056341</ArticleId><ArticleId IdType="pubmed">23441179</ArticleId><ArticleId IdType="pmc">3575343</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuta K, Aoki Y, Matoba Y et al (2014) Molecular epidemiology of enterovirus 71 strains isolated from children in Yamagata, Japan, between 1990 and 2013. J Med Microbiol 63:1356–1362. https://doi.org/10.1099/jmm.0.079699-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.079699-0</ArticleId><ArticleId IdType="pubmed">25053796</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Shi Y, Miao L et al (2021) Molecular epidemiology and recombination of Enterovirus A71 in mainland China from 1987 to 2017. Int Microbiol 24:291–299. https://doi.org/10.1007/s10123-021-00164-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10123-021-00164-2</ArticleId><ArticleId IdType="pubmed">33608776</ArticleId><ArticleId IdType="pmc">7895512</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y-P, Lin T-L, Lin T-H, Wu H-S (2013) Antigenic and Genetic Diversity of Human Enterovirus 71 from 2009 to 2012, Taiwan. PLoS ONE 8:e80942. https://doi.org/10.1371/journal.pone.0080942</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0080942</ArticleId><ArticleId IdType="pubmed">24348916</ArticleId><ArticleId IdType="pmc">3858369</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Regional Office for the Western Pacific (2018) Hand, Foot and Mouth Disease Situation Update 2018. WHO Regional Office for the Western Pacific, Manila</Citation></Reference><Reference><Citation>Pallansch MA, Oberste MS, Whitton J (2013) Enteroviruses: Polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. Fields Virol 490–530. https://doi.org/10.1002/0470857285.ch6</Citation></Reference><Reference><Citation>Takeuchi O, Akira S (2010) Pattern Recognition Receptors and Inflammation. Cell 140:805–820. https://doi.org/10.1016/j.cell.2010.01.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.01.022</ArticleId><ArticleId IdType="pubmed">20303872</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, Yan K, Wang C et al (2021) Intrinsic apoptosis and cytokine induction regulated in human tonsillar epithelial cells infected with enterovirus A71. PLoS ONE 16:e0245529. https://doi.org/10.1371/journal.pone.0245529</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0245529</ArticleId><ArticleId IdType="pubmed">33481814</ArticleId><ArticleId IdType="pmc">7822318</ArticleId></ArticleIdList></Reference><Reference><Citation>Swain SK, Panda S, Sahu BP, Sarangi R (2022) Activation of Host Cellular Signaling and Mechanism of Enterovirus 71 Viral Proteins Associated with Hand, Foot and Mouth Disease. Viruses 14:2190. https://doi.org/10.3390/v14102190</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14102190</ArticleId><ArticleId IdType="pubmed">36298746</ArticleId><ArticleId IdType="pmc">9609926</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J-R, Lu W-W, Lai J-Z et al (2013) Calcium flux and calpain-mediated activation of the apoptosis-inducing factor contribute to enterovirus 71-induced apoptosis. J Gen Virol 94:1477–1485. https://doi.org/10.1099/vir.0.047753-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.047753-0</ArticleId><ArticleId IdType="pubmed">23515028</ArticleId></ArticleIdList></Reference><Reference><Citation>Haolong C, Du N, Hongchao T et al (2013) Enterovirus 71 VP1 activates calmodulin-dependent protein kinase II and results in the rearrangement of vimentin in human astrocyte cells. PLoS ONE 8:e73900. https://doi.org/10.1371/journal.pone.0073900</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0073900</ArticleId><ArticleId IdType="pubmed">24073199</ArticleId><ArticleId IdType="pmc">3779202</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K-R, Ling P (2019) Interplays between Enterovirus A71 and the innate immune system. J Biomed Sci 26:95. https://doi.org/10.1186/s12929-019-0596-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0596-8</ArticleId><ArticleId IdType="pubmed">31787104</ArticleId><ArticleId IdType="pmc">6886175</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W, Wages PA, Devlin RB et al (2015) Src-Mediated EGF Receptor Activation Regulates Ozone-Induced Interleukin 8 Expression in Human Bronchial Epithelial Cells. Environ Health Perspect 123:231–236. https://doi.org/10.1289/ehp.1307379</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.1307379</ArticleId><ArticleId IdType="pubmed">25303742</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Han N, Xiao X et al (2014) Enterovirus 71 3C Inhibits Cytokine Expression through Cleavage of the TAK1/TAB1/TAB2/TAB3 Complex. J Virol 88:9830–9841. https://doi.org/10.1128/JVI.01425-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01425-14</ArticleId><ArticleId IdType="pubmed">24942571</ArticleId><ArticleId IdType="pmc">4136319</ArticleId></ArticleIdList></Reference><Reference><Citation>Leong SY, Ong BKT, Chu JJH (2015) The Role of Misshapen NCK-related kinase (MINK), a Novel Ste20 Family Kinase, in the IRES-Mediated Protein Translation of Human Enterovirus 71. PLoS Pathog 11:e1004686. https://doi.org/10.1371/journal.ppat.1004686</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004686</ArticleId><ArticleId IdType="pubmed">25747578</ArticleId><ArticleId IdType="pmc">4352056</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie G-C, Guo N-J, Grénman R et al (2016) Susceptibility of human tonsillar epithelial cells to enterovirus 71 with normal cytokine response. Virology 494:108–118. https://doi.org/10.1016/j.virol.2016.04.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.04.016</ArticleId><ArticleId IdType="pubmed">27107253</ArticleId></ArticleIdList></Reference><Reference><Citation>Madrid LV, Wang C-Y, Guttridge DC et al (2000) Akt Suppresses Apoptosis by Stimulating the Transactivation Potential of the RelA/p65 Subunit of NF-κB. Mol Cell Biol 20:1626–1638</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.20.5.1626-1638.2000</ArticleId><ArticleId IdType="pubmed">10669740</ArticleId><ArticleId IdType="pmc">85346</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv X, Qiu M, Chen D et al (2014) Apigenin inhibits enterovirus 71 replication through suppressing viral IRES activity and modulating cellular JNK pathway. Antiviral Res 109:30–41. https://doi.org/10.1016/j.antiviral.2014.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2014.06.004</ArticleId><ArticleId IdType="pubmed">24971492</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J, Hu Y, Li J et al (2018) Suppression of the toll-like receptor 7-dependent type I interferon production pathway by autophagy resulting from enterovirus 71 and coxsackievirus A16 infections facilitates their replication. Arch Virol 163:135–144. https://doi.org/10.1007/s00705-017-3592-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-017-3592-x</ArticleId><ArticleId IdType="pubmed">29052054</ArticleId></ArticleIdList></Reference><Reference><Citation>Du H, Yin P, Yang X et al (2015) Enterovirus 71 2C Protein Inhibits NF-κB Activation by Binding to RelA(p65). Sci Rep 5:14302. https://doi.org/10.1038/srep14302</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep14302</ArticleId><ArticleId IdType="pubmed">26394554</ArticleId><ArticleId IdType="pmc">4585786</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung W-H, Lee I-T, Hsieh H-L, Yang C-M (2010) EV71 induces COX-2 expression via c-Src/PDGFR/PI3K/Akt/p42/p44 MAPK/AP-1 and NF-κB in rat brain astrocytes. J Cell Physiol 224:376–386. https://doi.org/10.1002/jcp.22133</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.22133</ArticleId><ArticleId IdType="pubmed">20333648</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang D, Zhang C, Zhang R et al (2017) Involvement of inducible nitric oxide synthase and mitochondrial dysfunction in the pathogenesis of enterovirus 71 infection. Oncotarget 8:81014–81026. https://doi.org/10.18632/oncotarget.21250</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.21250</ArticleId><ArticleId IdType="pubmed">29113363</ArticleId><ArticleId IdType="pmc">5655258</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng B, Zhou X, Tian L et al (2022) IFN-β1b induces OAS3 to inhibit EV71 via IFN-β1b/JAK/STAT1 pathway. Virol Sin 37:676–684. https://doi.org/10.1016/j.virs.2022.07.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virs.2022.07.013</ArticleId><ArticleId IdType="pubmed">35934228</ArticleId><ArticleId IdType="pmc">9583119</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M-L, Lee Y-P, Wang Y-F et al (2005) Type I interferons protect mice against enterovirus 71 infection. J Gen Virol 86:3263–3269. https://doi.org/10.1099/vir.0.81195-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.81195-0</ArticleId><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CC, Liu CC, Chang YC et al (1999) Neurologic complications in children with enterovirus 71 infection. N Engl J Med 341:936–942. https://doi.org/10.1056/NEJM199909233411302</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411302</ArticleId><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Ennis J, Turner JD, Chu JJH (2016) Single dose of an adenovirus vectored mouse interferon-α protects mice from lethal EV71 challenge. Antiviral Res 134:207–215. https://doi.org/10.1016/j.antiviral.2016.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2016.09.003</ArticleId><ArticleId IdType="pubmed">27623347</ArticleId><ArticleId IdType="pmc">7113890</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghipour S, Bek EJ, McMinn PC (2013) Ribavirin-resistant mutants of human enterovirus 71 express a high replication fidelity phenotype during growth in cell culture. J Virol 87:1759–1769. https://doi.org/10.1128/JVI.02139-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02139-12</ArticleId><ArticleId IdType="pubmed">23175376</ArticleId><ArticleId IdType="pmc">3554166</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang S-H, Hwang L-H, Chen D-S, Chiang B-L (2000) Ribavirin enhancement of hepatitis C virus core antigen-specific type 1 T helper cell response correlates with the increased IL-12 level. J Hepatol 33:791–798. https://doi.org/10.1016/S0168-8278(00)80312-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-8278(00)80312-8</ArticleId><ArticleId IdType="pubmed">11097489</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuckerman E (2001) The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood 97:1555–1559. https://doi.org/10.1182/blood.V97.6.1555</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V97.6.1555</ArticleId><ArticleId IdType="pubmed">11238090</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai W, Bi J, Li F et al (2019) Antiviral Efficacy of Flavonoids against Enterovirus 71 Infection in Vitro and in Newborn Mice. https://doi.org/10.3390/v11070625 . Viruses 11:</Citation></Reference><Reference><Citation>Hu B, Chik KK-H, Chan JF-W et al (2022) Vemurafenib Inhibits Enterovirus A71 Genome Replication and Virus Assembly. Pharmaceuticals (Basel) 15. https://doi.org/10.3390/ph15091067</Citation></Reference><Reference><Citation>Zou X, Wu J, Gu J et al (2021) DNA aptamer against EV-A71 VP1 protein: selection and application. Virol J 18:164. https://doi.org/10.1186/s12985-021-01631-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-021-01631-y</ArticleId><ArticleId IdType="pubmed">34384436</ArticleId><ArticleId IdType="pmc">8359077</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Yang W, Zhang C et al (2021) Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial. Hum Vaccin Immunother 17:5348–5354. https://doi.org/10.1080/21645515.2021.2010428</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2021.2010428</ArticleId><ArticleId IdType="pubmed">34905446</ArticleId><ArticleId IdType="pmc">8903949</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F, Xu W, Xia J et al (2014) Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med 370:818–828. https://doi.org/10.1056/NEJMoa1304923</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1304923</ArticleId><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan X, Che Y, Wei S et al (2020) Effectiveness and Safety of an Inactivated Enterovirus 71 Vaccine in Children Aged 6–71 Months in a Phase IV Study. Clin Infect Dis 71:2421–2427. https://doi.org/10.1093/cid/ciz1114</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciz1114</ArticleId><ArticleId IdType="pubmed">31734699</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwa S-H, Lee YA, Brewoo JN et al (2013) Preclinical evaluation of the immunogenicity and safety of an inactivated enterovirus 71 candidate vaccine. PLoS Negl Trop Dis 7:e2538. https://doi.org/10.1371/journal.pntd.0002538</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002538</ArticleId><ArticleId IdType="pubmed">24244774</ArticleId><ArticleId IdType="pmc">3820736</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J-Y, Chang C-P, Tsai HH-P et al (2012) Selection and characterization of vaccine strain for Enterovirus 71 vaccine development. Vaccine 30:703–711. https://doi.org/10.1016/j.vaccine.2011.11.087</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.11.087</ArticleId><ArticleId IdType="pubmed">22142585</ArticleId></ArticleIdList></Reference><Reference><Citation>Yee PTI, Tan SH, Ong KC et al (2019) Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice. Sci Rep 9:4805. https://doi.org/10.1038/s41598-019-41285-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-41285-z</ArticleId><ArticleId IdType="pubmed">30886246</ArticleId><ArticleId IdType="pmc">6423319</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai Y-H, Huang S-W, Hsieh W-S et al (2019) Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate. J Virol 93. https://doi.org/10.1128/JVI.02308-18</Citation></Reference><Reference><Citation>Yang Z, Gao F, Wang X et al (2020) Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in Pichia pastoris. Hum Vaccin Immunother 16:1602–1610. https://doi.org/10.1080/21645515.2019.1649554</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2019.1649554</ArticleId><ArticleId IdType="pubmed">31403352</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H-J, Son HS, Lee SW et al (2019) Efficient expression of enterovirus 71 based on virus-like particles vaccine. PLoS ONE 14:e0210477. https://doi.org/10.1371/journal.pone.0210477</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0210477</ArticleId><ArticleId IdType="pubmed">30845175</ArticleId><ArticleId IdType="pmc">6405078</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei L, Li Q, Xu S et al (2021) Transplantation of Enterovirus 71 Virion Protein Particle Vaccine Protects Against Enterovirus 71 Infection in a Neonatal Mouse Model. Ann Transpl 26:e924461. https://doi.org/10.12659/AOT.924461</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AOT.924461</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox JA, Hiscox JA, Solomon T et al (2017) Immunopathogenesis and Virus–Host Interactions of Enterovirus 71 in Patients with Hand, Foot and Mouth Disease. Front Microbiol 8:2249. https://doi.org/10.3389/fmicb.2017.02249</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.02249</ArticleId><ArticleId IdType="pubmed">29238324</ArticleId><ArticleId IdType="pmc">5713468</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li J et al (2009) Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 15:798–801. https://doi.org/10.1038/nm.1992</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Ohka S, Fujii K, Koike S (2013) Functional Comparison of SCARB2 and PSGL1 as Receptors for Enterovirus 71. J Virol 87:3335–3347. https://doi.org/10.1128/JVI.02070-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02070-12</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId><ArticleId IdType="pmc">3592140</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Poh CL, Sam I-C, Chan YF (2013) Enterovirus 71 Uses Cell Surface Heparan Sulfate Glycosaminoglycan as an Attachment Receptor. J Virol 87:611–620. https://doi.org/10.1128/JVI.02226-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02226-12</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId><ArticleId IdType="pmc">3536405</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimojima M, Tano Y et al (2009) Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med 15:794–797. https://doi.org/10.1038/nm.1961</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Su P-Y, Liu Y-T, Chang H-Y et al (2012) Cell surface sialylation affects binding of enterovirus 71 to rhabdomyosarcoma and neuroblastoma cells. BMC Microbiol 12:162. https://doi.org/10.1186/1471-2180-12-162</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-12-162</ArticleId><ArticleId IdType="pubmed">22853823</ArticleId><ArticleId IdType="pmc">3478995</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Chuang H, Yang KD (2009) Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol J 6:141. https://doi.org/10.1186/1743-422X-6-141</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-6-141</ArticleId><ArticleId IdType="pubmed">19751532</ArticleId><ArticleId IdType="pmc">2751754</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Solakyildirim K, Chang Y, Linhardt RJ (2011) Hyphenated techniques for the analysis of heparin and heparan sulfate. Anal Bioanal Chem 399:541–557. https://doi.org/10.1007/s00216-010-4117-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00216-010-4117-6</ArticleId><ArticleId IdType="pubmed">20853165</ArticleId></ArticleIdList></Reference><Reference><Citation>Du N, Cong H, Tian H et al (2014) Cell Surface Vimentin Is an Attachment Receptor for Enterovirus 71. J Virol 88:5816–5833. https://doi.org/10.1128/JVI.03826-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03826-13</ArticleId><ArticleId IdType="pubmed">24623428</ArticleId><ArticleId IdType="pmc">4019121</ArticleId></ArticleIdList></Reference><Reference><Citation>Su P-Y, Wang Y-F, Huang S-W et al (2015) Cell Surface Nucleolin Facilitates Enterovirus 71 Binding and Infection. J Virol 89:4527–4538. https://doi.org/10.1128/JVI.03498-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03498-14</ArticleId><ArticleId IdType="pubmed">25673703</ArticleId><ArticleId IdType="pmc">4442404</ArticleId></ArticleIdList></Reference><Reference><Citation>He Q, Ren S, Xia Z et al (2018) Fibronectin Facilitates Enterovirus 71 Infection by Mediating Viral Entry. J Virol 92:e02251–e02217. https://doi.org/10.1128/JVI.02251-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02251-17</ArticleId><ArticleId IdType="pubmed">29467312</ArticleId><ArticleId IdType="pmc">5899198</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H-Y, Yang Y-T, Yu S-L et al (2013) Caveolar Endocytosis Is Required for Human PSGL-1-Mediated Enterovirus 71 Infection. J Virol 87:9064–9076. https://doi.org/10.1128/JVI.00573-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00573-13</ArticleId><ArticleId IdType="pubmed">23760234</ArticleId><ArticleId IdType="pmc">3754029</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Pang Z, Fan H, Tong Y (2023) Advances in anti-EV-A71 drug development research. J Adv Res S2090-1232(23)00089–9. https://doi.org/10.1016/j.jare.2023.03.007</Citation></Reference><Reference><Citation>Bavelloni A, Piazzi M, Raffini M et al (2015) Prohibitin 2: At a communications crossroads. IUBMB Life 67:239–254. https://doi.org/10.1002/iub.1366</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.1366</ArticleId><ArticleId IdType="pubmed">25904163</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim ZQ, Ng QY, Oo Y et al (2021) Enterovirus-A71 exploits peripherin and Rac1 to invade the central nervous system. EMBO Rep 22. https://doi.org/10.15252/embr.202051777</Citation></Reference><Reference><Citation>Tsou Y-L, Lin Y-W, Chang H-W et al (2013) Heat Shock protein 90: Role in Enterovirus 71 Entry and Assembly and Potential Target for Therapy. PLoS ONE 8:e77133. https://doi.org/10.1371/journal.pone.0077133</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0077133</ArticleId><ArticleId IdType="pubmed">24098578</ArticleId><ArticleId IdType="pmc">3788750</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K-M, Wu C-C, Wu S-E et al (2020) The RNA-dependent RNA polymerase of enterovirus A71 associates with ribosomal proteins and positively regulates protein translation. RNA Biol 17:608–622. https://doi.org/10.1080/15476286.2020.1722448</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2020.1722448</ArticleId><ArticleId IdType="pubmed">32009553</ArticleId><ArticleId IdType="pmc">7237135</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D et al (2010) Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 10:778–790. https://doi.org/10.1016/S1473-3099(10)70194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y, Cheng X, Yang X et al (2015) Early growth response-1 facilitates enterovirus 71 replication by direct binding to the viral genome RNA. Int J Biochem Cell Biol 62:36–46. https://doi.org/10.1016/j.biocel.2015.02.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2015.02.012</ArticleId><ArticleId IdType="pubmed">25724735</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Li Y (2019) Recent Progress on Functional Genomics Research of Enterovirus 71. Virol Sin 34:9–21. https://doi.org/10.1007/s12250-018-0071-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-018-0071-9</ArticleId><ArticleId IdType="pubmed">30552635</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H-I, Lin J-Y, Chiang H-C et al (2020) Exosomes Facilitate Transmission of Enterovirus A71 From Human Intestinal Epithelial Cells. J Infect Dis 222:456–469. https://doi.org/10.1093/infdis/jiaa174</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa174</ArticleId><ArticleId IdType="pubmed">32271384</ArticleId><ArticleId IdType="pmc">7336570</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao X-Y, Guo L, Huang D-Y et al (2014) Distribution of EV71 receptors SCARB2 and PSGL-1 in human tissues. Virus Res 190:40–52. https://doi.org/10.1016/j.virusres.2014.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.05.007</ArticleId><ArticleId IdType="pubmed">24997419</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Tijsma A, Mirabelli C et al (2019) Intra-host emergence of an enterovirus A71 variant with enhanced PSGL1 usage and neurovirulence. Emerg Microbes Infections 8:1076–1085. https://doi.org/10.1080/22221751.2019.1644142</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2019.1644142</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K, Ma Y, Zhang C et al (2012) [Neurologic complications in children with enterovirus 71-infected hand-foot-mouth disease: clinical features, MRI findings and follow-up study]. Zhonghua Yi Xue Za Zhi 92:1742–1746</Citation><ArticleIdList><ArticleId IdType="pubmed">22944180</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao T, Zhang Z, Zhang Y et al (2017) Dynamic Interaction of Enterovirus 71 and Dendritic Cells in Infected Neonatal Rhesus Macaques. Front Cell Infect Microbiol 7:171. https://doi.org/10.3389/fcimb.2017.00171</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2017.00171</ArticleId><ArticleId IdType="pubmed">28540257</ArticleId><ArticleId IdType="pmc">5423916</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C-S, Yao Y-C, Lin S-C et al (2007) Retrograde Axonal Transport: a Major Transmission Route of Enterovirus 71 in Mice. J Virol 81:8996–9003. https://doi.org/10.1128/JVI.00236-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00236-07</ArticleId><ArticleId IdType="pubmed">17567704</ArticleId><ArticleId IdType="pmc">1951457</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C-S, Liao C-C, Liou A-T et al (2019) Enterovirus 71 targets the cardiopulmonary system in a robust oral infection mouse model. Sci Rep 9:11108. https://doi.org/10.1038/s41598-019-47455-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-47455-3</ArticleId><ArticleId IdType="pubmed">31366973</ArticleId><ArticleId IdType="pmc">6668393</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Sun J, Wang N et al (2020) Enterovirus A71 capsid protein VP1 increases blood–brain barrier permeability and virus receptor vimentin on the brain endothelial cells. J Neurovirol 26:84–94. https://doi.org/10.1007/s13365-019-00800-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-019-00800-8</ArticleId><ArticleId IdType="pubmed">31512144</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y-C, Yu C-K, Wang Y-F et al (2004) A murine oral enterovirus 71 infection model with central nervous system involvement. J Gen Virol 85:69–77. https://doi.org/10.1099/vir.0.19423-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.19423-0</ArticleId><ArticleId IdType="pubmed">14718621</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong WX, Yan B, Yeo H et al (2012) A Non-Mouse-Adapted Enterovirus 71 (EV71) Strain Exhibits Neurotropism, Causing Neurological Manifestations in a Novel Mouse Model of EV71 Infection. J Virol 86:2121–2131. https://doi.org/10.1128/JVI.06103-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06103-11</ArticleId><ArticleId IdType="pubmed">22130542</ArticleId><ArticleId IdType="pmc">3302383</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang P-N, Jheng J-R, Arnold JJ et al (2017) UGGT1 enhances enterovirus 71 pathogenicity by promoting viral RNA synthesis and viral replication. PLoS Pathog 13:e1006375. https://doi.org/10.1371/journal.ppat.1006375</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006375</ArticleId><ArticleId IdType="pubmed">28545059</ArticleId><ArticleId IdType="pmc">5435352</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathinayake PS, Hsu AC-Y, Wark PAB (2015) Innate Immunity and Immune Evasion by Enterovirus 71. Viruses 7:6613–6630. https://doi.org/10.3390/v7122961</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7122961</ArticleId><ArticleId IdType="pubmed">26694447</ArticleId><ArticleId IdType="pmc">4690884</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Xiao X, Wang J (2016) Innate Immunity Evasion by Enteroviruses: Insights into Virus-Host Interaction. Viruses 8:22. https://doi.org/10.3390/v8010022</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v8010022</ArticleId><ArticleId IdType="pubmed">26784219</ArticleId><ArticleId IdType="pmc">4728582</ArticleId></ArticleIdList></Reference><Reference><Citation>Xagorari A, Chlichlia K (2008) Toll-Like Receptors and Viruses: Induction of Innate Antiviral Immune Responses. TOMICROJ 2:49–59. https://doi.org/10.2174/1874285800802010049</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874285800802010049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H, Takeuchi O, Sato S et al (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101–105. https://doi.org/10.1038/nature04734</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04734</ArticleId><ArticleId IdType="pubmed">16625202</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornung V, Ellegast J, Kim S et al (2006) 5’-Triphosphate RNA Is the Ligand for RIG-I. Science 314:994–997. https://doi.org/10.1126/science.1132505</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1132505</ArticleId><ArticleId IdType="pubmed">17038590</ArticleId></ArticleIdList></Reference><Reference><Citation>García-Sastre A (2017) Ten Strategies of Interferon Evasion by Viruses. Cell Host Microbe 22:176–184. https://doi.org/10.1016/j.chom.2017.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2017.07.012</ArticleId><ArticleId IdType="pubmed">28799903</ArticleId><ArticleId IdType="pmc">5576560</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowie AG, Unterholzner L (2008) Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol 8:911–922. https://doi.org/10.1038/nri2436</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2436</ArticleId><ArticleId IdType="pubmed">18989317</ArticleId><ArticleId IdType="pmc">7097711</ArticleId></ArticleIdList></Reference><Reference><Citation>Kontsek P (1994) Human type I interferons: structure and function. Acta Virol 38:345–360</Citation><ArticleIdList><ArticleId IdType="pubmed">7793359</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid E, Charleston B (2014) Type I and III Interferon Production in Response to RNA Viruses. J Interferon Cytokine Res 34:649–658. https://doi.org/10.1089/jir.2014.0066</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2014.0066</ArticleId><ArticleId IdType="pubmed">24956361</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Akira S (2011) Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity. Immunity 34:637–650. https://doi.org/10.1016/j.immuni.2011.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2011.05.006</ArticleId><ArticleId IdType="pubmed">21616434</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow J, Franz KM, Kagan JC (2015) PRRs are watching you: Localization of innate sensing and signaling regulators. Virology 479–480:104–109. https://doi.org/10.1016/j.virol.2015.02.051</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.02.051</ArticleId><ArticleId IdType="pubmed">25800355</ArticleId></ArticleIdList></Reference><Reference><Citation>McNab F, Mayer-Barber K, Sher A et al (2015) Type I interferons in infectious disease. Nat Rev Immunol 15:87–103. https://doi.org/10.1038/nri3787</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3787</ArticleId><ArticleId IdType="pubmed">25614319</ArticleId><ArticleId IdType="pmc">7162685</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo R-L, Chen Y-T, Li H-A et al (2021) Molecular determinants and heterogeneity underlying host response to EV-A71 infection at single-cell resolution. RNA Biol 18:796–808. https://doi.org/10.1080/15476286.2021.1872976</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2021.1872976</ArticleId><ArticleId IdType="pubmed">33406999</ArticleId><ArticleId IdType="pmc">8078531</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y, Liu J, Lu N, Zhang C (2021) Enterovirus 71 Antagonizes Antiviral Effects of Type III Interferon and Evades the Clearance of Intestinal Intraepithelial Lymphocytes. Front Microbiol 12:806084. https://doi.org/10.3389/fmicb.2021.806084</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.806084</ArticleId><ArticleId IdType="pubmed">35185830</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng K-F, Li M-L, Hung C-T, Shih S-R (2009) Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog 5:e1000593. https://doi.org/10.1371/journal.ppat.1000593</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000593</ArticleId><ArticleId IdType="pubmed">19779565</ArticleId><ArticleId IdType="pmc">2742901</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Wang B, Huang H et al (2017) Enterovirus 71 protease 2Apro and 3Cpro differentially inhibit the cellular endoplasmic reticulum-associated degradation (ERAD) pathway via distinct mechanisms, and enterovirus 71 hijacks ERAD component p97 to promote its replication. PLoS Pathog 13:e1006674. https://doi.org/10.1371/journal.ppat.1006674</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006674</ArticleId><ArticleId IdType="pubmed">28985237</ArticleId><ArticleId IdType="pmc">5650186</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S-H, Wang K, Zhao K et al (2020) The Structure, Function, and Mechanisms of Action of Enterovirus Non-structural Protein 2C. Front Microbiol 11:615965. https://doi.org/10.3389/fmicb.2020.615965</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.615965</ArticleId><ArticleId IdType="pubmed">33381104</ArticleId><ArticleId IdType="pmc">7767853</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L-C, Chen S-O, Chang S-P et al (2015) Enterovirus 71 Proteins 2A and 3D Antagonize the Antiviral Activity of Gamma Interferon via Signaling Attenuation. J Virol 89:7028–7037. https://doi.org/10.1128/JVI.00205-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00205-15</ArticleId><ArticleId IdType="pubmed">25926657</ArticleId><ArticleId IdType="pmc">4473548</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Li H, Zhang Z et al (2011) Enterovirus 71 2C protein inhibits TNF-α-mediated activation of NF-κB by suppressing IκB kinase β phosphorylation. J Immunol 187:2202–2212. https://doi.org/10.4049/jimmunol.1100285</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1100285</ArticleId><ArticleId IdType="pubmed">21810613</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Z, Wang Y, Bian L et al (2017) Enterovirus 71 antagonizes the antiviral activity of host STAT3 and IL-6R with partial dependence on virus-induced miR-124. J Gen Virol 98:3008–3025. https://doi.org/10.1099/jgv.0.000967</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000967</ArticleId><ArticleId IdType="pubmed">29120300</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng N, Zhou Z, Li Y et al (2017) Enterovirus 71-induced has-miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1. Virus Res 237:27–36. https://doi.org/10.1016/j.virusres.2017.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2017.05.008</ArticleId><ArticleId IdType="pubmed">28506791</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M-L, Hsu T-A, Chen T-C et al (2002) The 3C Protease Activity of Enterovirus 71 Induces Human Neural Cell Apoptosis. Virology 293:386–395. https://doi.org/10.1006/viro.2001.1310</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.1310</ArticleId><ArticleId IdType="pubmed">11886259</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang S-C, Lin J-Y, Lo LY-C et al (2004) Diverse apoptotic pathways in enterovirus 71–infected cells. J Neurovirol 10:338–349. https://doi.org/10.1080/13550280490521032</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280490521032</ArticleId><ArticleId IdType="pubmed">15765805</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang C-C, Sun M-J, Lei H-Y et al (2004) Human endothelial cell activation and apoptosis induced by enterovirus 71 infection. J Med Virol 74:597–603. https://doi.org/10.1002/jmv.20216</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20216</ArticleId><ArticleId IdType="pubmed">15484266</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L-C, Shyu H-W, Chen S-H et al (2006) Enterovirus 71 infection induces Fas ligand expression and apoptosis of Jurkat cells. J Med Virol 78:780–786. https://doi.org/10.1002/jmv.20623</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20623</ArticleId><ArticleId IdType="pubmed">16628611</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Lei H, Huang K et al (2003) Pathogenesis of Enterovirus 71 Brainstem Encephalitis in Pediatric Patients: Roles of Cytokines and Cellular Immune Activation in Patients with Pulmonary Edema. J INFECT DIS 188:564–570. https://doi.org/10.1086/376998</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/376998</ArticleId><ArticleId IdType="pubmed">12898444</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T-C, Lai Y-K, Yu C-K, Juang J-L (2007) Enterovirus 71 triggering of neuronal apoptosis through activation of Abl-Cdk5 signalling. Cell Microbiol 9:2676–2688. https://doi.org/10.1111/j.1462-5822.2007.00988.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2007.00988.x</ArticleId><ArticleId IdType="pubmed">17581253</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Qin Y, Wang T et al (2018) Pyroptosis induced by enterovirus 71 and coxsackievirus B3 infection affects viral replication and host response. Sci Rep 8:2887. https://doi.org/10.1038/s41598-018-20958-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-20958-1</ArticleId><ArticleId IdType="pubmed">29440739</ArticleId><ArticleId IdType="pmc">5811489</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L-Y (2004) Transmission and Clinical Features of Enterovirus 71 Infections in Household Contacts in Taiwan. JAMA 291:222. https://doi.org/10.1001/jama.291.2.222</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.291.2.222</ArticleId><ArticleId IdType="pubmed">14722149</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna M, Narang H (2008) The complexity of mitogen-activated protein kinases (MAPKs) made simple. Cell Mol Life Sci 65:3525–3544. https://doi.org/10.1007/s00018-008-8170-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-008-8170-7</ArticleId><ArticleId IdType="pubmed">18668205</ArticleId></ArticleIdList></Reference><Reference><Citation>Polosa R, Sapsford RJ, Dokic D et al (2004) Induction of the epidermal growth factor receptor and its ligands in nasal epithelium by ozone. J Allergy Clin Immunol 113:120–126. https://doi.org/10.1016/j.jaci.2003.09.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2003.09.040</ArticleId><ArticleId IdType="pubmed">14713916</ArticleId></ArticleIdList></Reference><Reference><Citation>Yogarajah T, Ong KC, Perera D, Wong KT (2017) AIM2 Inflammasome-Mediated Pyroptosis in Enterovirus A71-Infected Neuronal Cells Restricts Viral Replication. Sci Rep 7:5845. https://doi.org/10.1038/s41598-017-05589-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-05589-2</ArticleId><ArticleId IdType="pubmed">28724943</ArticleId><ArticleId IdType="pmc">5517550</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Xiao F, Wan P et al (2017) EV71 3D Protein Binds with NLRP3 and Enhances the Assembly of Inflammasome Complex. PLoS Pathog 13:e1006123. https://doi.org/10.1371/journal.ppat.1006123</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006123</ArticleId><ArticleId IdType="pubmed">28060938</ArticleId><ArticleId IdType="pmc">5245909</ArticleId></ArticleIdList></Reference><Reference><Citation>Itsui Y, Sakamoto N, Kurosaki M et al (2006) Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. J Viral Hepat 13:690–700. https://doi.org/10.1111/j.1365-2893.2006.00732.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2893.2006.00732.x</ArticleId><ArticleId IdType="pubmed">16970601</ArticleId></ArticleIdList></Reference><Reference><Citation>Long L, Wu L, Chen L et al (2021) Effect of early oxygen therapy and antiviral treatment on disease progression in patients with COVID-19: A retrospective study of medical charts in China. PLoS Negl Trop Dis 15:e0009051. https://doi.org/10.1371/journal.pntd.0009051</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0009051</ArticleId><ArticleId IdType="pubmed">33406076</ArticleId><ArticleId IdType="pmc">7815117</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X-W, Ni X, Qian S-Y et al (2018) Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition). World J Pediatr 14:437–447. https://doi.org/10.1007/s12519-018-0189-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-018-0189-8</ArticleId><ArticleId IdType="pubmed">30280313</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H, Huang L, Zhou J et al (2016) Efficacy and safety of interferon-α2b spray in the treatment of hand, foot, and mouth disease: a multicenter, randomized, double-blind trial. Arch Virol 161:3073–3080. https://doi.org/10.1007/s00705-016-3012-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-016-3012-7</ArticleId><ArticleId IdType="pubmed">27518403</ArticleId></ArticleIdList></Reference><Reference><Citation>Tate PM, Mastrodomenico V, Mounce BC (2019) Ribavirin Induces Polyamine Depletion via Nucleotide Depletion to Limit Virus Replication. Cell Rep 28:2620–2633e4. https://doi.org/10.1016/j.celrep.2019.07.099</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.07.099</ArticleId><ArticleId IdType="pubmed">31484073</ArticleId></ArticleIdList></Reference><Reference><Citation>Noshy MM, Hussien NA, El-Ghor AA (2013) Evaluation of the role of the antioxidant silymarin in modulating the in vivo genotoxicity of the antiviral drug ribavirin in mice. Mutat Res 752:14–20. https://doi.org/10.1016/j.mrgentox.2012.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrgentox.2012.12.012</ArticleId><ArticleId IdType="pubmed">23402882</ArticleId></ArticleIdList></Reference><Reference><Citation>Davoodi L, Masoum B, Moosazadeh M et al (2018) Psychiatric side effects of pegylated interferon–α and ribavirin therapy in Iranian patients with chronic hepatitis C: A meta–analysis. Exp Ther Med. https://doi.org/10.3892/etm.2018.6255</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2018.6255</ArticleId><ArticleId IdType="pubmed">30116347</ArticleId><ArticleId IdType="pmc">6090315</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieperink E, Ho SB, Thuras P, Willenbring ML (2003) A Prospective Study of Neuropsychiatric Symptoms Associated With Interferon-α-2b and Ribavirin Therapy for Patients With Chronic Hepatitis C. Psychosomatics 44:104–112. https://doi.org/10.1176/appi.psy.44.2.104</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.psy.44.2.104</ArticleId><ArticleId IdType="pubmed">12618532</ArticleId></ArticleIdList></Reference><Reference><Citation>Predescu O, Streba LA-M, Irimia E et al (2012) Adverse effects of peg-Interferon and Ribavirin combined antiviral treatment in a Romanian hepatitis C virus infected cohort. Rom J Morphol Embryol 53:497–502</Citation><ArticleIdList><ArticleId IdType="pubmed">23010773</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Simaeys D, López-Colón D, Sefah K et al (2010) Study of the Molecular Recognition of Aptamers Selected through Ovarian Cancer Cell-SELEX. PLoS ONE 5:e13770. https://doi.org/10.1371/journal.pone.0013770</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013770</ArticleId><ArticleId IdType="pubmed">21072169</ArticleId><ArticleId IdType="pmc">2967474</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuerk C, Gold L (1990) Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA Polymerase. Science 249:505–510. https://doi.org/10.1126/science.2200121</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.2200121</ArticleId><ArticleId IdType="pubmed">2200121</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Wen J, Li H et al (2019) Aptamer-Engineered Natural Killer Cells for Cell-Specific Adaptive Immunotherapy. Small 15:e1900903. https://doi.org/10.1002/smll.201900903</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/smll.201900903</ArticleId><ArticleId IdType="pubmed">31026116</ArticleId><ArticleId IdType="pmc">6541510</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Feng X, Yan X et al (2016) A DNA Aptamer Against Influenza A Virus: An Effective Inhibitor to the Hemagglutinin-Glycan Interactions. Nucleic Acid Ther 26:166–172. https://doi.org/10.1089/nat.2015.0564</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/nat.2015.0564</ArticleId><ArticleId IdType="pubmed">26904922</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen W, Qi Z, Wang J (2020) The Function and Mechanism of Enterovirus 71 (EV71) 3C Protease. Curr Microbiol 77:1968–1975. https://doi.org/10.1007/s00284-020-02082-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00284-020-02082-4</ArticleId><ArticleId IdType="pubmed">32556480</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu G, Qi J, Chen Z et al (2011) Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design. J Virol 85:10319–10331. https://doi.org/10.1128/JVI.00787-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00787-11</ArticleId><ArticleId IdType="pubmed">21795339</ArticleId><ArticleId IdType="pmc">3196414</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Song Z, Qin B et al (2013) Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: evaluation of antiviral efficacy in a murine infection model. Antiviral Res 97:264–269. https://doi.org/10.1016/j.antiviral.2012.12.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.12.029</ArticleId><ArticleId IdType="pubmed">23295352</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X-N, Song Z-G, Jiang T et al (2010) Rupintrivir is a promising candidate for treating severe cases of Enterovirus-71 infection. World J Gastroenterol 16:201–209. https://doi.org/10.3748/wjg.v16.i2.201</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v16.i2.201</ArticleId><ArticleId IdType="pubmed">20066739</ArticleId><ArticleId IdType="pmc">2806558</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Q, Xu Z, Jin M et al (2020) Identification of dibucaine derivatives as novel potent enterovirus 2C helicase inhibitors: In vitro, in vivo, and combination therapy study. Eur J Med Chem 202:112310. https://doi.org/10.1016/j.ejmech.2020.112310</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2020.112310</ArticleId><ArticleId IdType="pubmed">32619885</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y, Wang C, Wang C et al (2021) Antiviral Peptides Targeting the Helicase Activity of Enterovirus Nonstructural Protein 2C. J Virol 95. https://doi.org/10.1128/JVI.02324-20</Citation></Reference><Reference><Citation>Musharrafieh R, Kitamura N, Hu Y, Wang J (2020) Development of broad-spectrum enterovirus antivirals based on quinoline scaffold. Bioorg Chem 101:103981. https://doi.org/10.1016/j.bioorg.2020.103981</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bioorg.2020.103981</ArticleId><ArticleId IdType="pubmed">32559580</ArticleId><ArticleId IdType="pmc">7390679</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Y, Zhou X, Yang E et al (2012) Analysis of the Th1/Th2 Reaction in the Immune Response Induced by EV71 Inactivated Vaccine in Neonatal Rhesus Monkeys. J Clin Immunol 32:1048–1058. https://doi.org/10.1007/s10875-012-9690-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-012-9690-3</ArticleId><ArticleId IdType="pubmed">22585051</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Zhang Y, Wang J et al (2013) Study of the integrated immune response induced by an inactivated EV71 vaccine. PLoS ONE 8:e54451. https://doi.org/10.1371/journal.pone.0054451</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0054451</ArticleId><ArticleId IdType="pubmed">23372725</ArticleId><ArticleId IdType="pmc">3553120</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C-Y, Lin Y-W, Kuo C-H et al (2015) Inactivated Enterovirus 71 Vaccine Produced by 200-L Scale Serum-Free Microcarrier Bioreactor System Provides Cross-Protective Efficacy in Human SCARB2 Transgenic Mouse. PLoS ONE 10:e0136420. https://doi.org/10.1371/journal.pone.0136420</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0136420</ArticleId><ArticleId IdType="pubmed">26287531</ArticleId><ArticleId IdType="pmc">4543551</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng A, Fung C-P, Liu C-C et al (2013) A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine. Vaccine 31:2471–2476. https://doi.org/10.1016/j.vaccine.2013.03.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.03.015</ArticleId><ArticleId IdType="pubmed">23541623</ArticleId></ArticleIdList></Reference><Reference><Citation>Tambyah PA, Oon J, Asli R et al (2019) An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A phase I, double blind, randomized, placebo-controlled, study of two dosages. Vaccine 37:4344–4353. https://doi.org/10.1016/j.vaccine.2019.06.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.06.023</ArticleId><ArticleId IdType="pubmed">31230881</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Gao F, Zeng G et al (2021) Immunogenicity and Safety of Inactivated Enterovirus 71 Vaccine in Children Aged 36–71 Months: A Double-Blind, Randomized, Controlled, Non-inferiority Phase III Trial. J Pediatr Infect Dis Soc 10:440–447. https://doi.org/10.1093/jpids/piaa129</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piaa129</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Zhou C, Gao F et al (2021) Preclinical evaluation of recombinant HFMD vaccine based on enterovirus 71 (EV71) virus-like particles (VLP): Immunogenicity, efficacy and toxicology. Vaccine 39:4296–4305. https://doi.org/10.1016/j.vaccine.2021.06.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.06.031</ArticleId><ArticleId IdType="pubmed">34167837</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Ku Z, Liu Q et al (2015) High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice. Vaccine 33:2335–2341. https://doi.org/10.1016/j.vaccine.2015.03.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.03.034</ArticleId><ArticleId IdType="pubmed">25820068</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H-Y, Han J-F, Qin C-F, Chen R (2013) Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice. Vaccine 31:3281–3287. https://doi.org/10.1016/j.vaccine.2013.05.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.05.019</ArticleId><ArticleId IdType="pubmed">23726823</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y-G, Lee Y, Kim JH et al (2020) Self-Assembled Multi-Epitope Peptide Amphiphiles Enhance the Immune Response against Enterovirus 71. Nanomaterials (Basel) 10:. https://doi.org/10.3390/nano10122342</Citation></Reference><Reference><Citation>Andino R, Böddeker N, Silvera D, Gamarnik AV (1999) Intracellular determinants of picornavirus replication. Trends Microbiol 7:76–82. https://doi.org/10.1016/S0966-842X(98)01446-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0966-842X(98)01446-2</ArticleId><ArticleId IdType="pubmed">10081085</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Wang H, Chen Y et al (2017) Interleukin-18 protects mice from Enterovirus 71 infection. Cytokine 96:132–137. https://doi.org/10.1016/j.cyto.2017.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2017.04.002</ArticleId><ArticleId IdType="pubmed">28399485</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X, Zeng S, Ji X et al (2022) Type I Interferon-Induced TMEM106A Blocks Attachment of EV-A71 Virus by Interacting With the Membrane Protein SCARB2. Front Immunol 13:817835. https://doi.org/10.3389/fimmu.2022.817835</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.817835</ArticleId><ArticleId IdType="pubmed">35359978</ArticleId><ArticleId IdType="pmc">8963425</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H-P, Wang L, Qian J-H et al (2014) [Efficacy and safety of ribavirin aerosol in children with hand-foot-mouth disease]. Zhongguo Dang Dai Er Ke Za Zhi 16:272–276</Citation><ArticleIdList><ArticleId IdType="pubmed">24661520</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan S, Qian J, Gong X, Zhou Y (2014) [Effects of ribavirin aerosol on viral exclusion of patients with hand-foot-mouth disease]. Zhonghua Yi Xue Za Zhi 94:1563–1566</Citation><ArticleIdList><ArticleId IdType="pubmed">25146745</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Qiao H, Lv Y et al (2014) Apigenin inhibits enterovirus-71 infection by disrupting viral RNA association with trans-acting factors. PLoS ONE 9:e110429. https://doi.org/10.1371/journal.pone.0110429</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0110429</ArticleId><ArticleId IdType="pubmed">25330384</ArticleId><ArticleId IdType="pmc">4199717</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>